Drug intelligence / Profile preview

technetium Tc 99m albumin nanocolloid

Development stage
Unknown
Lead developer
Curium
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Nanoparticles → Drug Delivery Systems
Administration
Subcutaneous, Intravenous, Intradermal
01

Overview

Technetium Tc 99m albumin nanocolloid is a diagnostic radiopharmaceutical composed of human serum albumin particles of nanometer scale (typically 10 to 80 nm) labeled with the gamma-emitting radioisotope technetium-99m. Primarily used in nuclear medicine, it serves as a tracer for lymphoscintigraphy and bone marrow imaging. When administered subcutaneously, the small particle size allows for efficient entry into lymphatic capillaries and migration to regional lymph nodes, where the particles are sequestered by macrophages within the nodal sinuses. This makes it a gold standard for sentinel lymph node mapping in cancers such as melanoma and breast cancer. When administered intravenously, the particles are rapidly cleared from the circulation by the reticuloendothelial system (RES), allowing for scintigraphic visualization of the bone marrow, liver, and spleen, or the detection of inflammatory sites where capillary permeability is increased.

Brand names
NanocollAlbi-ResSolco Nanocoll
Other names
99mTc-NanocollTechnetium (99mTc) albumin nanocolloidTechnetium Tc 99m nanocolloidTc-99m human serum albumin nanocolloidTc99m human serum albumin nanocolloidTc 99m human serum albumin nanocolloid

Beyond the preview

Go deeper on technetium Tc 99m albumin nanocolloid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium Tc 99m albumin nanocolloid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call